Journal of Biochemistry and Biotechnology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Biochemistry and Biotechnology 44 7897 074717

Anti-Hemophilic-Factor-viii

Antihemophilic issue VIII and von willebrand  factor injection could be a combination product that's wont to treat serious bleeding episodes in patients with a bleeding problem known as von Willebrand disease (VWD). The bleeding episode could also be related to an injury (trauma) or a surgery. This medicine may also be used to stop bleeding, and to manage and stop bleeding episodes in patients with haemophilia A.

Antihemophilic factor VIII and von willebrand factor are ordinarily produced within the body. they assist clot the blood when an injury occurs. Patients with von willebrand disease or haemophilia A don't build enough of those substances to forestall bleeding; therefore this product is given to extend the levels of those substances within the blood.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Chemistry

Get the App